Vir Biotechnology, Inc.
Vir Biotechnology, Inc. (VIR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
vir · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 12 Wall Street analysts in the past 3 months
Buy
12 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$30.00
Consensus
$21.14
+151.6% upside
Low
$18.00
Median: $20 · Last Close: $8.40
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$21.14
151.6% upside
High Target
$30
257.0%
Low Target
$18
114.2%
Current Price
$8.40
as of today
Based on analyst price targets, the VIR stock price prediction for the next 12 months ranges from $18 to $30. The consensus VIR price forecast of $21.14 implies 151.6% upside from the current price of $8.40.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.22 | ↓ 2.17% |
1-day model range: $8.17–$8.27. Peak: $8.27 (-2.17%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -45.8% |
| 2028 | $3 | -59.5% |
| 2029 | $3 | -65.1% |
| 2030 | $3 | -67.8% |
| 2031 | — | -69.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · VIR · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-03 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-24 | Needham | Maintains | Buy→Buy |
| 2026-02-24 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-02-24 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-02-09 | Needham | Maintains | Buy→Buy |
| 2025-12-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-27 | B of A Securities | Upgrade ↑ | Neutral→Buy |
Wall Street analysts have recently issued updated ratings on Vir Biotechnology, Inc. (VIR) stock. Of the recent 95 rating actions, 9 were upgrades and 8 were downgrades. 12 analysts currently cover VIR.
Analyst Recommendation Trends
VIR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$162M
↑ 6.0% YoY
Revenue Next Year
$97M
↓ 40.1% YoY
EPS This Year
$-1.93
EPS Next Year
$-2.33
↑ 20.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast VIR EPS of $-1.93 for the current fiscal year, based on estimates from 4 analysts. The VIR revenue forecast is $162M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The VIR stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus VIR price target is $21.14 (+151.6% upside), with an analyst consensus of Buy.
The VIR short-term stock prediction for tomorrow is $8.22 (-2.17%). The VIR stock price prediction for 2027 estimates an average of $5. The VIR stock prediction for 2030 projects a range of $3–$3.
Vir Biotechnology, Inc. trades on NASDAQ under the ticker VIR. The VIR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 83% of covering analysts.
Frequently asked questions
VIR forecast · 8 questionsAccording to 12 Wall Street analysts, the average 12-month VIR price target is $21.14, with a high forecast of $30.00 and a low of $18.00. The median price target is shown in the chart above when available. This implies +151.6% potential upside from the current price of $8.40.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.